Intensive treatment of ovarian hyperstimulation syndrome. Clinical guidelines (treatment protocol)

L.V. Adamyan1, N.V. Artymuk2, T.E. Belokrinickaya3, A.V. Kulikov4, D.V. Marshalov5, A.P. Petrenko5, I.A. Salov5, O.S. Filippov6, E.M. Shifman7

1 FGBU «National medical research center for obstetrics, gynecology and perinatology named after V.I. Kulakov» Ministry of Health of Russia, Moscow

2 FGBOU VO “Kemerovo State Medical University” Ministry of Health of Russia, Kemerovo

3 FGBOU VO “Chita State Medical University” Ministry of Health of Russia, Chita

4 FGBOU VO “Uralʼsk State Medical University” Ministry of Health of Russia, Uralʼsk

5 FGBOU VO “Saratov State Medical University named after V.I. Razumovskij” Ministry of Health of Russia, Saratov

6 FGAOU VO “Moscow State Medical University named after I.M. Sechenov” Ministry of Health of Russia, Moscow

7 GBUZ MO “Moscow Regional Scientific Research Clinical Institute named after M.V. Vladimirsky”, Moscow

For correspondence: Marshalov Dmitrij — PhD, Associate Professor at the Department of Simulation Technologies and Emergency Medicine of the Saratov State Medical University named after V.I. Razumovskij, Saratov; e-mail: Marshald@mail.ru

For citation: Adamyan L.V., Artymuk N.V., Belokrinickaya T.E., Kulikov A.V., Marshalov D.V., Petrenko A.P., Salov I.A., Filippov O.S., Shifman E.M. Intensive treatment of ovarian hyperstimulation syndrome. Clinical guidelines (treatment protocol). Alexander Saltanov Intensive Care Herald. 2018;4:8–25.

DOI: 10.21320/1818-474X-2018-4-8-25


Ovarian hyperstimulation syndrome (OHSS) is a systemic disease that develops as a result of activation of the production of vasoactive mediators by the ovaries against the background of stimulation of superovulation. OHSS is characterized by an increase in the permeability of the capillary walls, which leads to the release of intravascular fluid into the extravascular space, its accumulation in the third space and hemoconcentration. Severe OHSS is characterized by the risk of thrombosis, impaired liver function, kidney function and the occurrence of adult respiratory distress syndrome (ARDS). In these clinical guidelines, the main provisions for the prognosis, diagnosis, prevention and intensive care of OHSS are presented, including the principles of treatment of intra-abdominal hypertension (IAH).

Keywords: ovarian hyperstimulation syndrome, intensive care, OHSS prevention

Received: 23.10.2018


References

  1. Boothroyd C., Karia S., Andreadis N., Rombauts L., Johnson N., Chapman M., Australasian CREI Consensus Expert Panel on Trial evidence (ACCEPT) group. Consensus statement on prevention and detection of ovarian hyperstimulation syndrome. Aust. N. Z. J. Obstet. Gynaecol. 2015; 55(6): 523–534. DOI: 10.1111/ajo.12406.
  2. Practice Committee of the American Society for Reproductive Medicine. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertil Steril. 2016; 106(7): 1634–47. DOI: 10.1016/j.fertnstert.2016.08.048.
  3. Royal College of Obstetricians and Gynaecologists. The Management of Ovarian Hyperstimulation Syndrome. Green-top Guideline No. 5. February 2016. London: RCOG, 2016.
  4. Carter R., Petrie K., Sadighi A., Skene H. Ovarian hyperstimulation syndrome on the acute medical unit: a problem-based review. Acute Med. 2015; 14(1): 21–27.
  5. Namavar Jahromi B., Parsanezhad M.E., Shomali Z., et al. Ovarian Hyperstimulation Syndrome: A Narrative Review of Its Pathophysiology, Risk Factors, Prevention, Classification, and Management. Iran. J. Med. Sci. 2018; 43(3): 248–260.
  6. Nelson S.M. Prevention and management of ovarian hyperstimulation syndrome. Thromb. Res. 2017; 151(Suppl. 1): S61–S64. DOI: 10.1016/S0049–3848(17)30070–1.
  7. Corbett S., Shmorgun D., Claman P. Reproductive Endocrinology Infertility Committee. The prevention of ovarian hyperstimulation syndrome. J. Obstet. Gynaecol. Can. 2014; 36(11): 1024–1036. DOI: 10.1016/S1701–2163(15)30417–5.
  8. Ironside E.C., Hotchen A.J. Ovarian hyperstimulation syndrome, the master of disguise? Case Rep. Emerg. Med. 2015; 2015: 510815. DOI: 10.1155/2015/510815.
  9. Sousa M., Cunha M., Teixeira da Silva J., et al. Ovarian hyperstimulation syndrome: a clinical report on 4894 consecutive ART treatment cycles. Reprod. Biol. Endocrinol. 2015; 13: 66. DOI: 10.1186/s12958-015-0067-3.
  10. Lamazou F., Legouez A., Letouzey V., et al. Ovarian hyperstimulation syndrome: pathophysiology, risk factors, prevention, diagnosis and treatment. J. Gynecol. Obstet. Biol. Reprod. (Paris). 2011; 40(7): 593–611. DOI: 10.1016/j.jgyn.2011.06.008.
  11. Wei L.H., Chou C.H., Chen M.W. The role of IL-6 trans-signaling in vascular leakage: implications for ovarian hyperstimulation syndrome in a murine model. J. Clin. Endocrinol. Metab. 2013; 98(3): 472–484. DOI: 10.1210/jc.2012-3462.
  12. Tan B.K., Mathur R. Management of ovarian hyperstimulation syndrome. Produced on behalf of the BFS Policy and Practice Committee. Hum. Fertil. (Camb). 2013; 16(3): 151–159. DOI: 10.3109/14647273.2013.788313.
  13. Youssef M.A., Mourad S. Volume expanders for the prevention of ovarian hyperstimulation syndrome. Cochrane Database Syst. Rev. 2016; (8): CD001302. DOI: 10.1002/14651858.CD001302.pub3.
  14. Grossman L.C., Michalakis K.G., Browne H., et al. The pathophysiology of ovarian hyperstimulation syndrome: an unrecognized compartment syndrome. Fertil. Steril. 2010; 94(4): 1392–1398. DOI: 10.1016/j.fertnstert.2009.07.1662.
  15. Chun R., Kirkpatrick A.W. Intra-abdominal pressure, intra-abdominal hypertension, and pregnancy: a review. Ann. Int. Care. 2012; 2(1): 5. DOI: 10.1186/2110-5820-2–S1-S5.
  16. Veisi F., Zangeneh M., Malekkhosravi S., Rezavand N. Abdominal Compartment Syndrome Due to OHSS. J. Obstet. Gynaecol. India. 2013; 63(5): 350–353. DOI: 10.1007/s13224-013-0480-5.
  17. Makino H., Furui T., Shiga T., et al. Management of ovarian hyperstimulation syndrome with abdominal compartment syndrome, based on intravesical pressure measurement. Reproductive Medicine and Biology. 2016; 16(1): 72–76. DOI: 10.1002/rmb2.12005. eCollection 2017 Jan.
  18. Malbrain M., De Waele J. Intra-abdominal hypertension (Core critical care). Cambridge: Cambridge University Press, 2013.
  19. Royal College of Obstetricians and Gynaecologists (RCOG). The management of ovarian hyperstimulation syndrome, Green-top Guideline № 5. London: RCOG, 2006.
  20. Maslovitz S., Jaffa A., Eytan O., et al. Renal blood flow alteration after paracentesis in women with ovarian hyperstimulation. Obstet. Gynecol. 2004; 104: 321–326.
  21. Sugrue M., Hallal A., D’Amours S. Intra-abdominal pressure hypertension and the kidney. In: Ivatury R., Cheatham M., Malbrain M., Sugrue M. (eds). Abdominal Compartment Syndrome. Georgetown: Landes Bioscience, 2006; 119–128.
  22. Delvigne A., Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum. Reprod. Update. 2002; 8: 559–577.
  23. Kimball E.J., Rollins M.D., Mone M.C. Survey of ICU physicians on the recognition and management of intra-abdominal hypertension and abdominal compartment syndrome. Crit. Care Med. 2006; 34: 2340–2348.
  24. Tiwari A., Myint F., Hamilton G. Recognition and management of abdominal compartment syndrome in the United Kingdom. Intensive Care Med. 2006; 32: 906–909.
  25. Lincoln S.R., Opsahl M.S., Blauer K.L., et al. Aggressive outpatient treatment of ovarian hyperstimulation syndrome with ascites using transvaginal culdocentesis and intravenous albumin minimizes hospitalization. J. Assist. Reprod. Genet. 2002; 19:159–163.
  26. The Prevention of Ovarian Hyperstimulation Syndrome. SOGC clinical practice guideline № 315. J. Obstet. Gynaecol. Can. 2014; 36(11): 1024–1033.
  27. Deeren D., Dits H., Malbrain M.L. Correlation between intra-abdominal and intracranial pressure in nontraumatic brain injury. Intensive Care Med. 2005; 31: 1577–1581.
  28. СаловИ.А., Шифман Е.М., Маршалов Д.В., Петренко А.П. Значение внутрибрюшной гипертензии в реализации акушерской и перинатальной патологии у беременных с ожирением. Акушерство и гинекология. 2012; 4(1): 99–102. [Salov I.A., Shifman E.M., Marshalov D.V., Petrenko A.P. The value of intra-abdominal hypertension in the implementation of obstetric and perinatal pathology in pregnant women with obesity. Obstetrics and gynecology. 2012; 4(1): 99–102. (in Russ)]
  29. ШапкинЮ.Г., Маршалов Д.В., Рогожина И.Е. и др. Зависимость исхода аппендэктомии у беременных от уровня внутрибрюшной гипертензии и показателей маточно-фето-плацентарного кровотока. Врач-аспирант. 2012; 5.1(54): 138–142. [Shapkin Yu.G., Marshalov D.V., Rogozhina I.E., et al. The dependence of the outcome of appendectomy in pregnant women on the level of intra-abdominal hypertension and indicators of uterine-feto-placental blood flow. The doctor-graduate student. 2012; 5.1(54): 138–142. (in Russ)]
  30. МаршаловД.В., Салов И.А., Петренко А.П. и др. Влияние внутрибрюшной гипертензии на исходы синдрома гиперстимуляции яичников. Анестезиология и реаниматология. 2013; 6: 42–47. [Marshalov D.V., Salov I.A., Shifman E.M., et al. Role of intra-abdominal hypertension in the development and outcome of ovarian hyperstimulation syndrome. Anesteziol Reanimatol. 2013; 6: 41–46. (in Russ)]
  31. Российская Ассоциация Репродукции Человека. РегистрВРТ. Отчет за 2015 год. Санкт-Петербург, 2017. [Russian Association of Human Reproduction. Register of ART. Report for 2015. St. Petersburg, 2017. (in Russ)]
  32. Российская Ассоциация Репродукции Человека. Регистр ВРТ. Отчет за2014 год. Санкт-Петербург, 2016. [Russian Association of Human Reproduction. Register of ART. Report for 2014. St. Petersburg, 2016. (in Russ)]
  33. European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J. Hepatol. 2010; 53(3): 397–417. DOI: 10.1016/j.jhep.2010.05.004.
  34. Raymond S.H. A survey of prescribing for the management of nausea and vomiting in pregnancy in Australasia. Aust. N. Z. J. Obstet. Gynaecol. 2013; 53(4): 358–362. DOI: 10.1111/ajo.12045.
  35. Wormer K.C., Jangda A.A., El Sayed F.A., et al. Is thromboprophylaxis cost effective in ovarian hyperstimulation syndrome: A systematic review and cost analysis. Eur. J. Obstet. Gynecol. Reprod. Biol. 2018; 224: 117–124. DOI: 10.1016/j.ejogrb.2018.03.028.
  36. Royal College of Obstetricians and Gynaecologists. Reducing the Risk of Venous Thromboembolism during Pregnancy and the Puerperium. Green-top Guideline No. 37a. London: RCOG, 2015.
  37. Afshari A., Ageno W., Ahmed A., et al. ESA VTE Guidelines Task Force. European Guidelines on perioperative venous thromboembolism prophylaxis: Executive summary. Eur. J. Anaesthesiol. 2018; 35(2): 77–83. DOI: 10.1097/EJA.0000000000000729.
  38. Lheureux O., Preiser J.C. Role of Nutrition Support in Inflammatory Conditions. Nutr. Clin. Pract. 2017; 32(3): 310–317. DOI: 10.1177/0884533617695242.
  39. Weimann A., Braga M., Carli F., et al. ESPEN guideline: Clinical nutrition in surgery. Clin. Nutr. 2017; 36(3): 623–650. DOI: 10.1016/j.clnu.2017.02.013.
  40. Reintam Blaser A., Starkopf J., Alhazzani W., et al. ESICM Working Group on Gastrointestinal Function. Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines. Intensive Care Med. 2017; 43(3): 380–398. DOI: 10.1007/s00134-016-4665-0.
  41. Amodio P., Bemeur C., Butterworth R. The nutritional management of hepatic encephalopathy in patients with cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus. Hepatology. 2013; 58(1): 325–336. DOI: 10.1002/hep.26370.
  42. Malbrain L.N.G., Cheatham M.L., Kirkpatrick A., Sugrue M. Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. Intensive Care Med. 2006; 32: 1722–1732.
  43. Российское общество-акушеров гинекологов. Федеральные клинические рекомендации. Диагностика и лечение синдрома гиперстимуляции яичников. Москва, 2013. [Russian Society of Obstetricians and Gynaecologists. Federal clinical guidelines. Diagnosis and treatment of ovarian hyperstimulation syndrome. Moscow, 2013. (in Russ)]
  44. Burch J.M., Moore E.E., Moore F.A., Franciose R. The abdominal compartment syndrome. Surg. Clin. North.Am. 1996; 76: 833–842.
  45. Маршалов Д.В., Петренко А.П. Роль хронической внутрибрюшной гипертензии в акушерской патологии. III Всероссийский образовательный конгресс «Анестезия и реанимация в акушерстве и неонатологии»: Материалы конгресса. М., 2010: 70–72. [Marshalov D.V., Petrenko A.P. The role of chronic intra-abdominal hypertension in obstetric pathology. III All-Russian Educational Congress “Anesthesia and Resuscitation in Obstetrics and Neonatology»: Congress materials. M, 2010: 70–72. (in Russ)]
  46. Vlahos N.F., Gregoriou O. Prevention and management of ovarian hyperstimulation syndrome. Ann. N. Y Acad. Sci. 2006; 1092: 247–264.
  47. Maslovitz S., Jaffa A., Eytan O., et al. Renal blood flow alteration after paracentesis in women with ovarian hyperstimulation. Obstet Gynecol. 2004; 104(2): 321–326.